On or around 01/31/2019 (Ongoing date of last review)
Filing Date: February 24, 2018
According to the Complaint, this is a shareholder class action brought on behalf of the former holders of PharMerica Corporation (“PharMerica” or the “Company”) common stock against PharMerica, its board of directors (the “Board”), Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Walgreens Boots Alliance, Inc. (“WBA”), for violations of federal law arising out of allegedly false and misleading statements made in connection with the go-private sale of the Company to KKR, with WBA as minority investor, for $29.25 per share in cash representing a deal valued at approximately $1.4 billion (“Merger”).
On July 30, 2018, Plaintiffs voluntarily dismissed all of their claims against one of the Defendants. On December 17, the Court issued an Order appointing Lead Plaintiff and Counsel.
Company & Securities Information
Defendant: Pharmerica Corporation
Industry: Medical Equipment & Supplies
Headquarters: United States
Company Market: Privately Traded
Market Status: Privately Held
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Laborers' Local #231 Pension Fund, et al. v. Pharmerica Corporation, et al.